Faculty profile

Joseph Blondeau

Back to faculty

ProfessorPathologyUniversity of Saskatchewan

Signals and details

Research

Read how they describe their research on their University of Saskatchewan profile.

Latest papers

Characterization of carbapenem-resistant Pseudomonas aeruginosa in Canadian hospitals: 6 years of the CANWARD study (2018-23).
The Journal of antimicrobial chemotherapy · 2025
Gram-negative pathogens from Canadian hospitals: 17 years of results from the CANWARD study (2007-23).
The Journal of antimicrobial chemotherapy · 2025
Gram-positive pathogens from Canadian hospitals: 17 years of results from the CANWARD study (2007-23).
The Journal of antimicrobial chemotherapy · 2025

All 12 publications

12 publications.

Characterization of carbapenem-resistant Pseudomonas aeruginosa in Canadian hospitals: 6 years of the CANWARD study (2018-23).

McCracken M, Walkty A, Adam HJ, Baxter M, Blondeau J, Lagacé-Wiens P, Karlowsky JA, Golding GR, Zhanel GG

The Journal of antimicrobial chemotherapy20255 citations

DOI: 10.1093/jac/dkaf222 PMID: 40873031

Gram-negative pathogens from Canadian hospitals: 17 years of results from the CANWARD study (2007-23).

Zhanel GG, Baxter MR, Lagacé-Wiens P, Walkty A, Fuller J, Davidson RJ, Blondeau J, Poutanen S, Lavallée C, Mataseje L, Golding G, Schweizer F, Bay D, Denisuik A, Li J, Karlowsky JA, Adam HJ

The Journal of antimicrobial chemotherapy20253 citations

DOI: 10.1093/jac/dkaf217 PMID: 40873026

Gram-positive pathogens from Canadian hospitals: 17 years of results from the CANWARD study (2007-23).

Zhanel GG, Baxter MR, Golden AR, Lagacé-Wiens P, Walkty A, Fuller J, Davidson RJ, Blondeau J, Poutanen S, Lavallée C, McCracken M, Golding G, Schweizer F, Bay D, Karlowsky JA, Adam HJ

The Journal of antimicrobial chemotherapy20251 citations

DOI: 10.1093/jac/dkaf263 PMID: 40873025

A nested cohort 5-year Canadian surveillance of Gram-negative antimicrobial resistance for optimized antimicrobial therapy.

Blondeau J, Charles MK, Loo V, Adam H, Gonzalez Del Vecchio M, Ghakis C, O'Callaghan E, El Ali R

Scientific reports20236 citationsFirst authorOpen Access

DOI: 10.1038/s41598-023-40012-z PMID: 37644048

Global update on the in vitro activity of tigecycline and comparators against isolates of Acinetobacter baumannii and rates of resistant phenotypes (2016-2018).

Seifert H, Blondeau J, Lucaßen K, Utt EA

Journal of global antimicrobial resistance2022

DOI: 10.1016/j.jgar.2022.08.002 PMID: 35948242

Bacteremia and polyarticular septic arthritis secondary to Moraxella bovis in a pregnant patient with HIV who injects drugs.

Danger B, Ripplinger C, Blondeau J, Blondeau L, Peermohamed S

Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada2022

DOI: 10.3138/jammi-2021-0027 PMID: 36337353

Clinical microbiology laboratories and COVID-19: an interview with Joseph Blondeau.

Blondeau J

Future microbiology2021First author

DOI: 10.2217/fmb-2021-0113 PMID: 34082568

In Vitro Time-Kill of Common Ocular Pathogens with Besifloxacin Alone and in Combination with Benzalkonium Chloride.

Blondeau J, DeCory H

Pharmaceuticals (Basel, Switzerland)2021First author

DOI: 10.3390/ph14060517 PMID: 34072129

International Society for Companion Animal Infectious Diseases (ISCAID) guidelines for the diagnosis and management of bacterial urinary tract infections in dogs and cats

Jeffrey Scott Weese, Joseph M. Blondeau, Dawn Merton Boothe, Luca Guardabassi, Nigel R. Gumley, Mark G. Papich, Lisbeth Rem Jessen, Michael R. Lappin, Shelley C. Rankin, Jodi L. Westropp, Jane E. Sykes

The Veterinary Journal2019466 citationsOpen Access

DOI: 10.1016/j.tvjl.2019.02.008 PMID: 30971357

Reporting elevated vancomycin minimum inhibitory concentration in methicillin-resistant Staphylococcus aureus: consensus by an International Working Group.

Wilcox M, Al-Obeid S, Gales A, Kozlov R, Martínez-Orozco JA, Rossi F, Sidorenko S, Blondeau J

Future microbiology2019Senior author

DOI: 10.2217/fmb-2018-0346 PMID: 30724113

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Joseph Blondeau

Research

Latest papers

Characterization of carbapenem-resistant Pseudomonas aeruginosa in Canadian hospitals: 6 years of the CANWARD study (2018-23).

Gram-negative pathogens from Canadian hospitals: 17 years of results from the CANWARD study (2007-23).

Gram-positive pathogens from Canadian hospitals: 17 years of results from the CANWARD study (2007-23).

A nested cohort 5-year Canadian surveillance of Gram-negative antimicrobial resistance for optimized antimicrobial therapy.

Global update on the in vitro activity of tigecycline and comparators against isolates of Acinetobacter baumannii and rates of resistant phenotypes (2016-2018).

Bacteremia and polyarticular septic arthritis secondary to Moraxella bovis in a pregnant patient with HIV who injects drugs.

Clinical microbiology laboratories and COVID-19: an interview with Joseph Blondeau.

In Vitro Time-Kill of Common Ocular Pathogens with Besifloxacin Alone and in Combination with Benzalkonium Chloride.

International Society for Companion Animal Infectious Diseases (ISCAID) guidelines for the diagnosis and management of bacterial urinary tract infections in dogs and cats

Reporting elevated vancomycin minimum inhibitory concentration in methicillin-resistant Staphylococcus aureus: consensus by an International Working Group.

Frequent collaborators

Heather Adam

Philippe Lagacé-Wiens

Andrew Walkty

James Karlowsky

Denice Bay

Frank Schweizer

George Golding

Susan Poutanen

Haron Obaid

Vivian Loo

Paul Babyn

Scott Weese

Joseph Blondeau

Research

Latest papers

Characterization of carbapenem-resistant Pseudomonas aeruginosa in Canadian hospitals: 6&#x2005;years of the CANWARD study (2018-23).

Gram-negative pathogens from Canadian hospitals: 17 years of results from the CANWARD study (2007-23).

Gram-positive pathogens from Canadian hospitals: 17&#x2005;years of results from the CANWARD study (2007-23).

A nested cohort 5-year Canadian surveillance of Gram-negative antimicrobial resistance for optimized antimicrobial therapy.

Global update on the in vitro activity of tigecycline and comparators against isolates of Acinetobacter baumannii and rates of resistant phenotypes (2016-2018).

Bacteremia and polyarticular septic arthritis secondary to Moraxella bovis in a pregnant patient with HIV who injects drugs.

Clinical microbiology laboratories and COVID-19: an interview with Joseph Blondeau.

In Vitro Time-Kill of Common Ocular Pathogens with Besifloxacin Alone and in Combination with Benzalkonium Chloride.

International Society for Companion Animal Infectious Diseases (ISCAID) guidelines for the diagnosis and management of bacterial urinary tract infections in dogs and cats

Reporting elevated vancomycin minimum inhibitory concentration in methicillin-resistant Staphylococcus aureus: consensus by an International Working Group.

Frequent collaborators

Heather Adam

Philippe Lagacé-Wiens

Andrew Walkty

James Karlowsky

Denice Bay

Frank Schweizer

George Golding

Susan Poutanen

Haron Obaid

Vivian Loo

Paul Babyn

Scott Weese

Characterization of carbapenem-resistant Pseudomonas aeruginosa in Canadian hospitals: 6 years of the CANWARD study (2018-23).

Gram-positive pathogens from Canadian hospitals: 17 years of results from the CANWARD study (2007-23).